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Abstract
Background: UK guidance recommend all acute medical admissions be offered an HIV test. Our aim was to determine
whether a dedicated staff member using a multimedia tool, a model found to be effective in the USA, is an acceptable,
feasible, and cost-effective model when translated to a UK setting.
Design: Between 14th Jan to 12th May 2010, a Health advisor (HA) approached 19–65 year olds at a central London acute
medical admissions unit (AAU) and offered a rapid HIV point of care test (POCT) with the aid of an educational video.
Patients with negative results had the option to watch a post-test video providing risk-reduction information. For reactive
results the HA arranged a confirmatory test, and ensured linkage into HIV specialist care. Feasibility and acceptability were
assessed through surveys and uptake rates. Costs per case of HIV identified were established.
Results: Of the 606 eligible people admitted during the pilot period, 324 (53.5%) could not be approached or testing was
deemed inappropriate. In total 23.0% of eligible admissions had an HIV POCT. Of the patients who watched the video and had
not recently tested for HIV, 93.6% (131/140) agreed to an HIV test; four further patients had an HIV test but did not watch the
video. Three tests (2.2%, 3/135) were reactive and all were confirmed HIV positive on laboratory testing. 97.5% felt HIV
testing in this setting was appropriate, and 90.1% liked receiving the information via video. The cost per patient of the
intervention was £21.
Discussion: Universal POCT HIV testing in an acute medical setting, facilitated by an educational video and dedicated staff
appears to be acceptable, feasible, effective, and low cost. These findings support the recommendation of HIV testing all
admissions to AAU in high prevalence settings, although with the model used a significant proportion remained untested.
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Introduction
Late presentation to HIV services is the single most preventable
cause of HIV related morbidity and mortality [1]. Late pre-
sentation also means a person must have been living with
undiagnosed HIV infection for a substantial period of time, and
people with undiagnosed HIV infection disproportionately
contribute to onward transmission of the infection [2]. For these
reasons, and for the associated increase in healthcare costs that
late presentation brings [3], HIV prevention efforts have
increasingly focused on improving opportunities to have an HIV
test so as to reduce both late presentation and undiagnosed HIV
infection [4–6].
The Jacobi Medical Center and North Bronx Healthcare
Network (NBHN), New York, developed Project B.R.I.E.F.
(Behavior intervention, Rapid HIV test, Innovative video,
Efficient cost and health care savings, Facilitated seamless linkage
to outpatient HIV care). This program uses a ‘‘public health
advocate’’(PHA) to recruit stable patients attending an inner-city
emergency department. It uses a model of universal testing with no
specific population targeted. A multimedia tool (tablet PC) is used
to deliver a validated video for HIV pre-test counselling (the video
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lasts ,90 seconds and is available in 2 languages), followed by
a rapid POCT. A post-test video, viewed while the individual waits
for the test results, delivers risk reduction counselling and
education. The educational videos are as effective as in-person
counselling in conveying information related to testing [7]. Basic
demographic and risk factor data are collected through this tool
using touch screen technology. Using this model, of 7109 eligible
patients who watched the video, 87% (6218) were tested,
identifying 57 new infections [8].
The publication of the National guidelines on HIV testing [9] in
2008 led to a number of initiatives to assess the feasibility,
acceptability and cost effectiveness of new models of delivery for
HIV testing. Our aim was to determine whether a model of care
utilising a multimedia tool and dedicated staff and found to be
effective in an emergency medical setting in New York, is an
acceptable, feasible and cost effective model in reducing late
presentation of HIV infection when translated to a UK setting.
Methods
Ethics Statement
The local Research Ethics Committee, part of the National
Research Ethics Service, waived requiring formal ethical approval
under SL24 Project not considered to be research, version 4.0
April 2009, as they regarded the pilot as service evaluation.
Data was collected on all new admissions to an acute admission
unit (AAU) in Central London over a 16 week period (15th Jan to
11th May 2010 inclusive). Adults aged 19–65 in a stable clinical
condition were eligible for inclusion in the HIV testing pilot.
Patients who were only on the AAU during the weekend when the
HIV testing service was not available were excluded from this
analysis.
The service model employed consisted of a health advisor (HA)
approaching all new stable admissions, and offering HIV testing
with the aid of an educational video available in up to 4 languages.
If patient accepted, a finger prick rapid HIV point of care test
(POCT) was performed using the EU approved INSTITM test
(sensitivity and specificity reported elsewhere) [10]. If the result
was HIV negative the patient had the option of watching a post-
test video providing risk-reduction information. If the result was
reactive the HA explained the need for a confirmatory test,
arranged the test and urgent follow up with the HIV service. All
patients watching either video completed a questionnaire designed
to evaluate patient satisfaction and collect process evaluation data
(demographic and behavioural profiles). The questionnaire was
delivered electronically with touch-screen technology via the tablet
PC that patients used to watch the videos.
The video scripts were adapted from those used in Project
BRIEF to suit a UK context and to meet BHIVA guidelines [9].
They were pretested in two focus groups with service providers
and users. At the time of the pilot only an audio English version
was available but now versions exist with English, French, Polish,
and Spanish subtitles.
The tablet PC and all equipment necessary for the POCT tests
were located on a small portable trolley that was wheeled to the
bedside. Disposable headsets were used so as not to disturb other
patients.
Following the completion of the project all staff who worked on
the unit during the pilot period were surveyed about their
experiences. Surveys were distributed at meetings for those still
working on the unit and via email to those now located elsewhere.
Standard statistical tests, e.g. Chi2 test and Student’s t-test, were
used to examine associations between variables.
We directly calculated the incremental cost of the educational
video intervention versus treatment as usual from a National
Health Service (NHS) perspective. The cost components
included in the analysis were video equipment costs, cost of
disposable equipment and staff costs incurred through training,
delivering the intervention and post-test counselling. Resource
use data for each cost component were collected in the study.
We applied unit costs from market prices and published sources
[11]. We conservatively assumed that the lifetime of the video
equipment was approximately 1000 patients. The majority of
the costs incurred were staff costs. We assumed in our main
analysis that these would be incurred by a Health Advisor
(Band 7), based on 3 tests per hour. In sensitivity analyses we
explored the impact of using different staff and increasing the
number of tests per hour.
Results
During the study period there were 606 eligible (19 to 65 years
of age inclusive and inpatient on weekday) admissions to the AAU,
representing 602 individuals. As none of the repeat attendees had
an HIV test on their first visit both visits are included in
subsequent analyses. Three quarters (456/606, 75.3%) of all
eligible admissions were approached to participate in the study.
There were no significant differences in the gender, age, ethnicity,
presentation pattern or length of stay between those approached
and not approached (table 1).
Despite often multiple attempts, over half (53.5%) of approaches
failed to encounter or engage the patient (table 2). Of the
282 patients whom were asked if they would be involved in the
pilot project, 153 (54.3%) agreed. On introduction of video four
patients asked or agreed to have an HIV test but did not want to
watch the video, and five disclosed that they had recently tested for
HIV and therefore withdrew from further involvement. Following
the video a further eleven patients declined to test: four had tested
within the past three months; two had never been sexually active;
two declined because of communication difficulties; one wanted to
test in an anonymous environment and was referred to the local
sexual health clinic; one became unwell during the video; and one
declined. In all, of the 140 patients who watched the video and
had not tested for HIV in the preceding three months, 93.6%
(131/140) agreed to an HIV test. All patients tested received their
results at the time of testing.
Older people (aged 40 years or more) were less likely to accept
to watch the video than younger patients (43.4% vs. 64.2%, p =
0.001), however if they did so uptake of the test did not differ by
age (71.8% vs. 76.9%, p = 0.476). There was no difference in the
uptake of the video or HIV test by gender.
In total 23.0% of eligible admissions to AAU during the pilot
period had a POCT HIV test, and 25.7% left AAU knowing their
HIV status having tested on that admission or within the
preceding three months, or previously been diagnosed HIV
positive. Three tests (2.2%, 3/135) were reactive on POCT and all
were confirmed HIV positive on further laboratory testing.
The three patients diagnosed HIV positive were a 48 year old
British man with pneumonia, presumed Pneumocystis jirovecii
pneumonia (PCP), CD4 20; a 42 year old Nigerian woman
admitted with bacterial pneumonia, CD4 40; and a 60 year old
British man with rectal bleeding on warfarin, CD4 590. All three
patients were seen by specialist HIV services whilst an inpatient
and remain engaged with HIV services 12 months on. Only one of
the three had previously tested for HIV, the 48 year old British
man having tested over 5 years previously.
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Respondent Characteristics
The majority of RAPID participants (patients who watched the
video and completed the survey) were male (58.6%), and the
median age was 38.5 years. Over half (51.9%) resided in the
hospital catchment area (local boroughs of Camden or Islington),
and 85.5% were from within London. Over two fifths (42.8%) of
participants were born abroad: 19 (12.5%) in Europe, 17 (11.2%)
in Africa (9, 5.9% black African) and 15 (9.9%) in Asia or the
Indian sub-continent. During the pilot the video was only available
in spoken English (subsequently versions with English, French,
Polish and Spanish subtitles have been developed), despite this
87.5% of patients stated the video was in their preferred language.
Forty percent (61/152) of participants had previously had an
HIV test, however only 22 (14.5%) had tested within the past
12 months and 19 (12.5%) had tested more than 5 years
previously. Five participants who had previously tested (14.8%,
5/61) reported they never received the results of their last HIV
test. Almost 20% of participants reported behaviour associated
with increased risk for HIV (table 3). Prior HIV testing was more
prevalent in those reporting an HIV risk behaviour than those who
did not (75.0% vs. 32.8%, p,0.001).
Patient Acceptability
The overwhelming majority (97.5%) of participants of the
RAPID pilot thought POCT HIV testing in the AAU was a good
idea, and 96.7% thought rapid HIV testing appropriate in this
setting. Almost all (90.1%, 137/152) participants liked receiving
information via video, and the majority (80.3%, 133/152) felt the
short video answered their questions about HIV testing. The
main reason for patients not liking the use of video was because
they would prefer face to face interaction (11/14); two patients
also mentioned that they were not able to ask questions they
wanted to, and another two felt the leaflet introducing the
project had already provided sufficient information. Participants
were asked if the Health advisor running the pilot made it easy
to get tested: 82.9% responded ‘yes, very’, 10.5% ‘yes, a little’,
and 5.9% ‘not sure’.
Finally participants were asked how they would prefer rapid
HIV testing to be offered: 2.6% preferred video alone, 15.8%
a health advisor alone, 9.2% a combination of health advisor and
leaflet, 46.1% the combination of video and health advisor, and
25.7% a combination of health advisor, video and leaflet.
Acceptability to Staff
Responses were obtained from 61.5% (88/143) of clinical staff
working on AAU during the pilot; the response rate was lower
amongst doctors of all grades (50%), than among nurses and
health care assistants (74.1%). No staff felt the service had
disrupted their job in any way, and all staff felt the service should
be continued. 92% of doctors believed that more of their own
patients were now tested for HIV (table 4), and no doctors felt the
service made them less likely to offer a test; with three-quarters of
doctors believing the service increased the likelihood of them
requesting an HIV test either directly or via the service.
Regular POCT testing on AAU continued until June 25th, and
the number of standard laboratory HIV test requests in AAU in
the five months preceding and during pilot did not significantly
differ (data not shown).
Cost
The additional cost of the equipment required for the
educational video was £1709 (Table 5). The incremental cost of
the education video intervention per patient was £21 (Table 6).
The largest component of the cost was the staff cost to run the
video and test and associated administration (49% of the total
Table 1. Characteristics of eligible patients admitted to AAU during pilot.
Characteristic Total (N=606)% Approached (n=456)% P value
Male 56.8 56.6 0.892
Age (years) (median age 44) 0.126
19–35 32.7 34.4
36–65 67.3 65.6
Ethnicity (n = 590) 0.726
British 42.4 42.7
African 4.7 4.3
Other/not stated 52.9 53.0
Indicator disease* present during admission (n = 591) 13.5 13.2 0.695
Inpatient ,48 hours 53.9 53.6 0.842
*As defined in National Guidelines on HIV testing [9].
doi:10.1371/journal.pone.0035212.t001
Table 2. Outcome to bedside approach.
Of 606 eligible admissions: N (%)
Known HIV positive 7 (1.2%)
Patient discharged 44 (7.3%)
Patient absent 64 (10.6%)
Patient too unwell1 107 (17.7%)
Unable to consent2 56 (9.2%)
Other3 38 (3.0%)
Tested already4 8 (1.3%)
Consent sought 282 (46.5%)
1Ward staff provided information on who should not be approached due to ill
health on daily basis.
2Usually due to intoxication or psychiatric illness.
3Includes relatives or friends visiting, eating, language barriers and with staff.
4HIV test already performed during current admission.
doi:10.1371/journal.pone.0035212.t002
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incremental cost). The cost per case identified was £1,083. If the
costs of disposable equipment were excluded on the basis that
these would have been incurred in any case, then the incremental
cost of the education video per patient fell from £21 to £15. If the
service was provided by a Nurse Band 5 rather than a Health
advisor Band 7 the cost per patient fell from £21 to £18. If it was
provided by a Healthcare Assistant they fell to £14. If 6 rather
than 3 tests were undertaken per hour then the costs per patient
were £16, £14 and £12, depending on whether the staff member
involved was a Health advisor Band 7, Nurse Band 5 or
Healthcare Assistant.
Discussion
Routine HIV point of care testing in the AAU setting was
acceptable to patients. It was successful in identifying cases of HIV
and demonstrates the potential for earlier diagnosis in screening
those without indicator diseases. Using a service model with
a dedicated staff member compared to one where HIV testing is
embedded within routine clinical practice undoubtedly increased
costs, however the cost per case identified still compares
favourably with other screening programmes in the UK [12].
The provision of a dedicated staff member also ensured staff
acceptability and no disruption to current services.
For this pilot we deliberately used a senior Health Advisor with
a lot of experience in delivering HIV results however with
appropriate training and support a more junior staff member
could run the service. In project BRIEF in New York, this role is
fulfilled by ‘Public Health Advocates’, who usually have no formal
clinical training other than the two weeks of training they get once
employed on the project.
The use of digital media (the video) ensured consistent
messaging, and that information was conveyed in an easy manner
for patients with health literacy or literacy issues. Digital media has
the ability to overcome linguistic issues, to be flexible around
patient care, and can be delivered on sustainable system wide
tools, for example patient television. Furthermore the use of video
was liked by patients although the survey data suggests that face to
face contact time remains important. Unfortunately different
models of service delivery, such as video or health advisor alone,
were not able to be assessed in the current study.
Table 3. Reporting of HIV risk factors by gender (n = 147).
Ever reported: Total (N=147) Men (N=85) Women (N=62)
% (n) % (n) % (n)
Previous STI 9.5% (14) 11.8% (10) 6.5% (4)
Injecting drug use 1.4% (2) 2.4% (2) 0
Sex with a man who has sex with men 7.5% (11) 10.6% (9) 3.2% (2)
Sex with an HIV positive person 1.4% (2) 1.2% (1) 1.6% (1)
Sex with a person who uses injection drugs 2.7% (4) 3.5% (3) 1.6% (1)
None of the above 81% (119) 76.5% (65) 87.1% (54)
doi:10.1371/journal.pone.0035212.t003
Table 4. Staff attitudes and experiences of RAPID project.
Doctors (n =44)
Nurses & Health-care
Assistants (n=40)
Aware of service 93% 85%
Is this service:
Not needed – –
Useful 30% 21%
Very useful 60% 38%
No opinion 10% 11%
Influence of a dedicated person offering HIV tests on the number of own patients having an
HIV test:
More people now tested 92% 85%
Less people now tested 3% –
No change in number tested 5% 15%
Influence of having a dedicated HIV testing service on requesting an HIV test from patients
More likely to offer test directly 35% Not applicable
More likely to ask RAPID service to offer test 40% Not applicable
Less likely to request test as assume will occur as part of RAPID – Not applicable
Not changed my practice 25% Not applicable
doi:10.1371/journal.pone.0035212.t004
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For the purposes of this paper costings are based on the first
1000 patients seen however the video equipment would be
expected to last well beyond the first 1000 patients and subsequent
costs would reduce accordingly. 22% of all patients aged 19–
65 years were admitted to the AAU and subsequently discharged
between 5 pm Friday and 9 am Monday and thus excluded from
this study. These patients were likely to be younger (mean age
40 versus 44 years) but there was no gender difference compared
with patients on AAU during testing hours. The authors would
expect more alcohol related admissions over weekends but
whether this directly equates with HIV risk is unknown.
The main criticism of this model could be that it fails to embed
HIV testing within routine clinical practice, often referred to as
‘normalising HIV’ [13]. This is a concern that the authors share,
however without the will of clinical colleagues in other specialties,
sustained routine HIV testing within general medical practice in
the UK currently appears to elude us; the notable exception to this
of course being the hugely successful universal antenatal screening
programme [14]. Implementation of the HIV antenatal screening
programme was supported by specific national health policy [15].
While guidelines have been published recommending expansion of
HIV testing opportunities to setting such as AAUs these fall short
of policy recommendations.
A further criticism could be that two of the three cases identified
were likely to have been detected through the already locally
established practice of targeted testing of high risk individuals as
defined by indicator disease or risk group [16], and that expanding
practice to universal testing is unnecessary. The authors would
certainly like to believe that the two cases with indicator diseases
would have been identified without the RAPID pilot in place,
unfortunately published data suggests that this may not necessarily
have occurred [16,17]. Earlier diagnosis is increasingly acknowl-
edged as fundamental in prevention of HIV related morbidity and
mortality, and in the prevention of onward transmission of
infection. Testing based on indicator diseases, as found in the
current study, is unlikely to identify people in the early stages of
HIV infection. The third case, the 60 year-old gentleman
admitted with rectal bleeding, reported no high risk behavior
and to our knowledge had never accessed sexual health services;
without universal testing his HIV would almost certainly have
remained undetected until presenting at some later date with
advanced disease.
No difference was found between those approached and not
approached in terms of gender, ethnicity, patient stay, or indicator
disease status, suggesting the pilot used a truly non targeted
approach. Generalisability to other clinical settings however is
hindered by the highly specific population and setting of the study.
HIV case-finding outside of the London AAU setting is likely to
influence the cost-effectiveness of the model.
For any screening procedure to be viable it must fulfill certain
criteria, often called the Wilson-Jungner criteria [18]. The criteria
are listed in short below followed by findings based on current
study.Wilson-Jungner Screening Criteria and HIV testing in AAUs.
N The condition that is being sought must be sufficiently common in the group
being screened to make screening worthwhile.
Taking those already known to be HIV positive (n = 7) and
those newly diagnosed (n= 3) the diagnosed HIV positive
prevalence in the AAU setting was 1.7% (10/606) – suggesting
AAU is a highly appropriate location to target HIV testing in areas
of high prevalence.
N Screening will lead to earlier detection of a treatable disease so that outcome
is significantly improved.
Universal screening has lead to early detection in one of the
three cases identified. Earlier detection of HIV is associated with
reduced short term and all cause mortality [19,20].
N The screening technique has acceptable costs per case identified and the
procedure is acceptable to both patients and staff.
Even at the highest cost estimate of £1083 per case identified,
this program demonstrated reasonable cost and acceptability to
staff and patients.
N There will be a high enough uptake to make the procedure valid.
Uptake of the POCT test was extremely high once patients
watched the video. Alternative strategies such as universal offer of
POCT HIV test in the absence of video were not explored in the
current pilot.
N There will be high specificity (low rate of false positives) and a very high
sensitivity (very low rate of false negatives).
The specificity of the test is marketed at 99.5% and the
sensitivity at 97.5% [10].
N Investigation and management of positive results will not overburden the
system.
Having a dedicated staff member minimizes potential disruption
to services. They can arrange confirmatory testing, post test
counselling, and linkage into HIV care. All test results are
delivered at the time of testing.
Implications
It is estimated that prevention of one new HIV infection in the
UK saves between £280,000 and £360,000 in direct lifetime
healthcare costs [21]. Thirty five Primary care Trusts in England
Table 5. Equipment costs.
Equipment Cost (ex VAT)
1
£
Start up costs (excluding video production2)
Toshiba Portege M750-13c T58703 979
Simple-smart Laptop Cart4 325
Kensington Micro Saver Disc Lock3 29.99
Sharps bin 1.73
SNAP Survey software license 373.75
Total: 1709.47
Disposables (per test performed)
INSTi kits 6.50
Disposable Gloves 0.05
Lightweight Stereo Headphones 0.88
Pulp tray 0.03
Total: 7.46
1As bought in December 2009.
2The videos are available free of charge from corresponding author so this cost
would not need to be replicated if same service was to be implemented
elsewhere.
3Supplied by Misco.
4Supplied by RDP Health.
doi:10.1371/journal.pone.0035212.t005
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have a prevalence of diagnosed HIV greater than 2 per 1,000
adult population. Whilst failing to embed HIV testing within
routine clinical practice, utilization of a model of universal POCT
HIV testing in an acute medical setting, facilitated by an
educational video and dedicated staff may play an important role
in the transition to normalization of HIV testing, as this model
appears to be acceptable to both staff and patients, feasible,
effective, and cost-effective.
With minimal staff training this model could also be adapted to
one of universal POCT testing within routine clinical care. A
clearly identified pathway to link those with reactive tests into
specialist care for confirmatory testing, post test counselling, and
linkage into care should ideally support any such initiative, ideally
through the provision of a HIV liaison nurse/health advisor.
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